Can a nerve block make sinus surgery less bloody?
NCT ID NCT03970655
First seen Jun 24, 2026 · Last updated Jul 31, 2026 · Updated 3 times
Summary
This pilot study tests whether adding epinephrine to a standard nerve block (pterygopalatine ganglion block) reduces bleeding during functional endoscopic sinus surgery (FESS) in people with chronic rhinosinusitis. Eighty adults undergoing bilateral FESS will receive the nerve block with epinephrine on one side and without on the other, and surgeons will rate bleeding using a standard scale. The goal is to see if this simple addition can improve surgical conditions.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- bupivacaine or ropivacaine with epinephrine plus dexamethasone
- What this could lead to
- If it works, this could lead to a simple way to reduce bleeding during sinus surgery, making the procedure safer and easier for surgeons.
- What could go wrong
- This is a small early-phase pilot study, so results may not be conclusive. The effect on bleeding might be small or not clinically meaningful.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1/2
Runs two stages together: safety and dose first, then whether the treatment works.
- Participants
-
80 people
The number who actually took part.
- Started
-
Sep 2019
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patient presenting for bilateral FESS 2. Adult patients (\>18 and \< 90 years old) 3. Patient consents to participate 4. No underlying chronic pain condition 5. No underlying bleeding diathesis Exclusion Criteria: 1. Patient refuses to consent 2. Patient requires revision or unilateral surgery 3. Patient requires surgery in addition to FESS 4. Age younger than 18 or older than 90 years 5. Any underlying chronic pain condition 6. History of bleeding diathesis 7. Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for block placement. 8. Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for research participation. 9. Vulnerable patient population
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic rhinosinusitis (diagnosis) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UF Health of University of Florida
Gainesville, Florida, 32610, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Viruses that kill bacteria: a new weapon against superbugs?
- Sugar alcohol rinse could soothe sinus pain in cystic fibrosis
- Could a cystic fibrosis drug ease stubborn sinus infections?
- Could viruses and epigenetics be the hidden cause of chronic sinusitis?
- New sinus implant aims to unblock noses and ease facial pain
- Sinus study pulled before it even started